White House calls Arizona a coronavirus success story as state resets after huge spike in cases
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
RICHMOND, Va. — Virginia has rolled out a smartphone app to automatically notify people if they might have been exposed to the coronavirus, becoming the first U.S. state to use new pandemic technology created by Apple and Google.
Submitted by mike kraft on
Nearly every country has struggled to contain the coronavirus and made mistakes along the way.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Though 33 states now have face mask mandates, Gov. Pete Ricketts says his state of Nebraska will not be joining them. On Monday, Ricketts doubled down on his conviction that a statewide mask mandate would be too “heavy-handed.”
Submitted by mike kraft on
U.S. testing for the coronavirus is dropping even as infections remain high and the death toll rises by more than 1,000 a day, a worrisome trend that officials attribute largely to Americans getting discouraged over having to wait hours to get a test and days or weeks to learn the results.
Submitted by mike kraft on
Scientists are beginning to untangle one of the most complex biological mysteries of the coronavirus pandemic: Why do some people get severely sick, whereas others quickly recover?
Submitted by mike kraft on
NEW BRUNSWICK, New Jersey, Aug. 5, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen's SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval or Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Since April, the Trump administration has funneled $48 million into a program with the Mayo Clinic, allowing more than 53,000 Covid-19 patients to get plasma infusions. Doctors and hospitals desperate to save the sickest patients have been eager to try a therapy that is safe and might work. Tens of thousands more people are now enrolled to get the treatment that’s been trumpeted by everyone from the president to the actor Dwayne Johnson, better known as The Rock.
Submitted by mike kraft on
So far, most of the conversation about COVID-19 vaccines has focused on the question of whether researchers can develop an effective vaccine in record time.
But maybe we should start asking another question as well: Will enough Americans actually get the vaccine for it to be effective?
“It’s not a vaccine that will save us,” says Harvard Global Health Institute director Ashish Jha. “It’s vaccination.”
Submitted by mike kraft on
http://www.thelancet-press.com/embargo/hcwcovid.pdf
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
Summary Background Data for front-line health-care workers and risk of COVID-19 are limited. We sought to assess risk of COVID-19 among front-line health-care workers compared with the general community and the effect of personal protective equipment (PPE) on risk.